🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
10.01
-0.18 (-1.77%)
Nov 19, 2026, 4:00 PM EST - Market closed

Corvus Pharmaceuticals Statistics

Total Valuation

CRVS has a market cap or net worth of $844.37 million. The enterprise value is $642.06 million.

Market Cap844.37M
Enterprise Value 642.06M

Important Dates

The last earnings date was Thursday, November 5, 2026, after market close.

Earnings Date Nov 5, 2026
Ex-Dividend Date n/a

Share Statistics

CRVS has 84.35 million shares outstanding. The number of shares has increased by 18.80% in one year.

Current Share Class 84.35M
Shares Outstanding 84.35M
Shares Change (YoY) +18.80%
Shares Change (QoQ) +0.13%
Owned by Insiders (%) 3.54%
Owned by Institutions (%) 74.31%
Float 73.02M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 4.05
P/TBV Ratio 4.05
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 13.38, with a Debt / Equity ratio of 0.00.

Current Ratio 13.38
Quick Ratio 13.25
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -45.92% and return on invested capital (ROIC) is -30.06%.

Return on Equity (ROE) -45.92%
Return on Assets (ROA) -27.83%
Return on Invested Capital (ROIC) -30.06%
Return on Capital Employed (ROCE) -32.50%
Weighted Average Cost of Capital (WACC) 12.62%
Revenue Per Employee n/a
Profits Per Employee -$1.74M
Employee Count37
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +10.12% in the last 52 weeks. The beta is 1.52, so CRVS's price volatility has been higher than the market average.

Beta (5Y) 1.52
52-Week Price Change +10.12%
50-Day Moving Average 10.91
200-Day Moving Average 13.78
Relative Strength Index (RSI) 42.95
Average Volume (20 Days) 973,724

Short Selling Information

The latest short interest is 17.76 million, so 21.05% of the outstanding shares have been sold short.

Short Interest 17.76M
Short Previous Month 17.97M
Short % of Shares Out 21.05%
Short % of Float 24.32%
Short Ratio (days to cover) 16.48

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -67.75M
Pretax Income -64.32M
Net Income -64.32M
EBITDA -67.57M
EBIT -67.75M
Earnings Per Share (EPS) -$0.72
Full Income Statement

Balance Sheet

The company has $202.95 million in cash and $632,000 in debt, with a net cash position of $202.31 million or $2.40 per share.

Cash & Cash Equivalents 202.95M
Total Debt 632,000
Net Cash 202.31M
Net Cash Per Share $2.40
Equity (Book Value) 208.32M
Book Value Per Share 2.47
Working Capital 190.93M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$47.18 million and capital expenditures -$764,000, giving a free cash flow of -$47.94 million.

Operating Cash Flow -47.18M
Capital Expenditures -764,000
Depreciation & Amortization 184,000
Net Borrowing n/a
Free Cash Flow -47.94M
FCF Per Share -$0.57
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CRVS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -18.80%
Shareholder Yield -18.80%
Earnings Yield -7.21%
FCF Yield -5.68%

Analyst Forecast

The average price target for CRVS is $31.50, which is 214.69% higher than the current price. The consensus rating is "Strong Buy".

Price Target $31.50
Price Target Difference 214.69%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2